A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Abed, Thuraya Salim
- Dosing of Erythropoietin Stimulating Agents in Patients on Hemodialysis: A Single-Center Study
Authors
1 Lecturer, Baghdad Medical City Campus, Ministry of Health and Environment, Al-Esraa University College, Baghdad, IQ
2 Asst. Prof., Department of Pharmacy, Al-Esraa University College, Baghdad, IQ
Source
Indian Journal of Public Health Research & Development, Vol 10, No 11 (2019), Pagination:Abstract
Objective: Study the relationship of dialysis adequacy with the effectiveness of erythropoietin for the management of anemia in hemodialysis patients.
Materials and Method: A retrospective cohort study, conducted in the Medical city complex from January 2019 to June 2019, the study involved 162 ESRD patients on regular hemodialysis sessions.
Results: Change in Hb (percentage and value), was significantly higher in patients receiving once-weekly erythropoietin compared to both twice and thrice and more dosing per week. Overall only 33 (21.2%) of the patients achieved target Hb (10-11 mg/dL) with 6 months of follow-up. There was an inverse significant correlation between percentage change after 6 months with baseline Hb, baseline ferritin, and baseline albumin. While with urea at baseline, number of weekly sessions, and Kt/V the relationship becomes direct and significant. There is an increased risk (2 folds) of not achieving target Hb (10-11 mg/dL) in patients with DM compared to those without DM.
Conclusion: Once weekly regimen appeared to superior to other regimens (twice or more per week).
Keywords
Erythropoietin, Dialysis, Hemoglobin, Anemia, Weekly Dosing.
- Dosing of Erythropoietin Stimulating Agents in Patients on Hemodialysis: A Single-Center Study
Authors
1 Baghdad Medical City Campus, Ministry of Health and Environment, IQ
2 Department of Pharmacy, Al-Esraa University College, Baghdad, IQ
Source
Indian Journal of Public Health Research & Development, Vol 11, No 2 (2020), Pagination: 1924-1929Abstract
Objective: Study the relationship of dialysis adequacy with the effectiveness of erythropoietin for the management of anemia in hemodialysis patients.
Materials and Method: A retrospective cohort study, conducted in the Medical city complex from January 2019 to June 2019, the study involved 162 ESRD patients on regular hemodialysis sessions.
Results: Change in Hb (percentage and value), was significantly higher in patients receiving once-weekly erythropoietin compared to both twice and thrice and more dosing per week. Overall only 33 (21.2%) of the patients achieved target Hb (10 – 11 mg/dL) with 6 months of follow-up. There was an inverse significant correlation between percentage change after 6 months with baseline Hb, baseline ferritin, and baseline albumin. While with urea at baseline, number of weekly sessions, and Kt/V the relationship becomes direct and significant There is an increased risk (2 folds) of not achieving target Hb (10-11 mg/dL) in patients with DM compared to those without DM.
Conclusion: Once weekly regimen appeared to superior to other regimens (twice or more per week).